Medivation, Inc. Announces Participation at Upcoming Investor Conferences
Published: Dec 03, 2012
SAN FRANCISCO, CA--(Marketwire - November 29, 2012) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:
- David Hung, M.D., president and chief executive officer, will present at the Deutsche Bank BioFEST Conference on December 3 at 9:35am Eastern Time in Boston, MA.
- David Hung, M.D., president and chief executive officer, will present at the JP Morgan Healthcare Conference on January 7 at 4:30pm Pacific Time in San Francisco, CA.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
Chief Business & Financial Officer